The 3.1 percentage point dip in obesity represents the first real decline the US has seen in several decades. Some observers suggest obesity could become rare within 10 years if the current pace of drug adoption and weight loss continues.
Wednesday, October 21, 2026
Story
US Obesity Drops to 36.8% After GLP-1 Use Hits 11%
US Markets10 days ago
Approximately 28 million adults in the United States now take GLP-1 medications for weight loss, up from a 3% adoption rate in 2024. This surge in drug use aligns with a decrease in the national obesity rate to 36.8% this year from 39.9% in 2022, according to Gallup and health data.
Looking for more context or analysis?
Tilt chat provides reliable, tailored insights, alerts, and automations.